Cart
sales@molnova.com
AG-1517
CAS No. 153436-54-5
AG-1517 ( PD153035 )
Catalog No. M12162 CAS No. 153436-54-5
PD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 52 | In Stock |
|
| 25MG | 109 | In Stock |
|
| 50MG | 203 | In Stock |
|
| 100MG | 354 | In Stock |
|
| 200MG | 530 | In Stock |
|
| 500MG | 831 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG-1517
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.
-
DescriptionPD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.
-
SynonymsPD153035
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number153436-54-5
-
Formula Weight360.21
-
Molecular FormulaC16H14BrN3O2
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCOC1=C(OC)C=C2C(NC3=CC(Br)=CC=C3)=NC=NC2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
-
HKI-357
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.
-
Lapatinib ditosylate
A reversible, selective dual tyrosine kinase inhibitor of both EGFR and ErbB2 with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively.
-
Sapitinib
Sapitinib (AZD-8931, AZD8931) is a equipotent, reversible inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4. 3 and 4 nM (phosphorylation inhibition), respectively.
